Summary: Current clinical evidence does not show that GLP-1 medications cause thyroid cancer in humans, despite thyroid tumours observed in animal studies
This dual action makes survodutide especially interesting for patients who struggle with belly fat or fatty liver disease , two conditions that raise risks for diabetes, heart disease, and shorter lifespan
never skip escalation steps [6]
This ensures consistent and harmonized BE standards for both IR and qualifying MR products
If you experience persistent side effects such as nausea or vomiting, contact your GP or diabetes specialist nurse for advice on appropriate dose adjustments, slower titration, or alternative treatments
In particular, poly(I:C), a synthetic viral RNA mimic, increased GLP-1 release in mice [1-2]